Lifestyle
- Regular exercise
- Adequate hydration
- Stress management
Serum Globulin · Gesamtglobulin
Globulin measures the concentration of a group of proteins in the blood that are involved in immune function and other biological processes.
Reference ranges may vary slightly between laboratories. No significant sex-specific differences.
Globulin is a group of proteins in the blood, produced primarily by the liver, that play a critical role in immune function, blood clotting, and other essential biological processes. It is measured as part of the total protein in blood tests, with albumin being the other major component. Researchers have found that globulin levels can reflect liver function, immune status, and nutritional state. Clinically, abnormal globulin levels may indicate liver disease, kidney disease, or immune disorders. Elevated globulin levels can be associated with chronic inflammatory diseases, infections, or multiple myeloma, while low levels may suggest liver dysfunction or nephrotic syndrome. For athletes and biohackers, maintaining optimal globulin levels is crucial for immune resilience and overall health. However, globulin levels can be influenced by various factors such as hydration status, acute illness, and medication use. Researchers observed that fasting status and time of day generally do not significantly affect globulin measurements, making it a stable marker for routine health assessments.
Klinische Bedeutung
Elevated globulin levels may indicate chronic inflammation, infections, or hematological disorders like multiple myeloma. Reduced levels can suggest liver dysfunction, nephrotic syndrome, or protein-losing enteropathy.
Progressively rising globulin levels may suggest worsening chronic inflammation or liver disease. Re-test in 4 weeks if outside the optimal range.
Progressively falling globulin levels may indicate improving inflammation or potential liver or kidney issues.
Re-test Interval
4 weeks if outside optimal range
Note:
Consult a healthcare provider for personalized advice, especially if underlying conditions are suspected.
Testing Frequency
Annually for routine health checks, more frequently if monitoring a specific condition.
Correlated with
Current research suggests that reference ranges for sex hormone-binding globulin (SHBG) may vary significantly across populations, and optimal targets for therapeutic interventions in conditions like polycystic ovary syndrome (PCOS) remain debated. Researchers have not yet established the precise confounders affecting SHBG levels, such as genetic variants and lifestyle factors. Additionally, unanswered clinical questions include the long-term efficacy of SHBG-raising therapies in preventing type 2 diabetes and the role of SHBG in various metabolic disorders.
726
Total Citations
14
Human/RCT
4.0
Avg. Influence
2026
Latest
This study examined diagnostic efficiency for tuberculous pericarditis and found that elevated serum globulin levels (>40 g/l) were independently predictive of the disease. A diagnostic model incorporating various clinical and laboratory features achieved high sensitivity and specificity for identifying tuberculous pericarditis. Researchers highlight the importance of basic clinical and laboratory features in aiding diagnosis.
Researchers found that sex hormone-binding globulin (SHBG) levels are negatively correlated with non-alcoholic fatty liver disease and insulin resistance. Low SHBG levels may contribute to the progression of polycystic ovary syndrome (PCOS) by increasing androgen bioavailability. The study suggests that SHBG could serve as a diagnostic biomarker and therapeutic target for managing PCOS.
Researchers reviewed the clinical applications of sex hormone-binding globulin (SHBG) as a biomarker. They highlighted its role in various conditions, including hormonal disorders and cancers, and discussed how SHBG levels can be influenced by metabolic factors. This study emphasizes the potential of SHBG as a surrogate marker in clinical practice.
Researchers explored the clinical significance of corticosteroid-binding globulin (CBG) levels and identified genetic variants affecting CBG function. The study noted associations between altered CBG levels and conditions like hypertension and metabolic syndrome, although the nature of these associations remains uncertain. Further research is needed to clarify CBG's role in health and disease.
Researchers observed that genetic variants affecting serum sex hormone-binding globulin (SHBG) levels are linked to metabolic syndrome and type 2 diabetes. The study suggests a causal role for SHBG as a hepatokine in women, indicating potential for SHBG-raising therapies to prevent or treat these disorders. This highlights the importance of SHBG in metabolic health.
Researchers discussed the challenges in diagnosing primary antibody deficiency (PAD) and highlighted the potential of using calculated globulin levels as a screening tool. The study emphasizes the need for integrated approaches combining clinical data and laboratory results to reduce diagnostic delays in patients with suspected PAD. This could improve early detection and management.
Researchers observed that higher serum globulin levels (>3.8 g/dL) are associated with increased all-cause and infection-related mortality in hemodialysis patients. The study emphasizes the need to further investigate the mechanisms behind elevated globulin levels and their impact on patient outcomes.
Researchers studied the significance of elevated serum globulin fraction in inflammatory bowel disease (IBD) patients over four years. They found that a high globulin fraction is associated with greater disease severity and increased healthcare utilization. This study suggests globulin fraction may serve as a biomarker for disease trajectory in IBD.
This study examined autoimmune hepatitis, characterized by elevated serum globulin levels and the presence of autoantibodies. Researchers found that recurrence of autoimmune hepatitis post-liver transplantation is common, affecting 36%-68% of recipients. Early diagnosis and treatment are crucial to prevent graft loss and improve patient outcomes.
This study focused on the variability in postpartum Rh immune globulin dosing based on laboratory estimations of fetal red blood cells. Researchers noted that current methods, including the acid-elution assay, are subjective and imprecise, suggesting a need for more accurate techniques like flow cytometry. The study emphasizes the importance of accurate dosing to prevent underdosing in RhD-negative mothers.
Research publications about Globulin over time
9totalLog lab results, track trends and optimize your biomarkers over time.
This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer